Navigation Links
Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
Date:6/29/2009

SOUTHAMPTON, England, June 29 /PRNewswire/ -- Vantia Therapeutics, an emerging pharmaceutical company developing novel, small molecule drugs targeting large, underserved medical markets, announces positive results from a Phase IIa clinical trial of its lead development compound VA106483 for nocturia. The trial showed that oral VA106483 was successful in producing a predictable and sustained anti-diuretic effect in patients, as determined by increased osmolality and decreased urine output. The study also found that VA106483 was generally well tolerated among the patient population.

Nocturia (defined as waking frequently to urinate at night thereby disturbing sleep significantly) is a common condition, with prevalence increasing markedly with age. It is often the presenting symptom in men with benign prostatic hypertrophy (BPH) and affects at least 70% of BPH patients. There is currently no adequate treatment for nocturia and it represents a potential market estimated at more than US$500 million.

VA106483 is a novel small molecule drug candidate that exerts its effect directly in the kidney by binding to vasopressin (V2) receptors, which regulate water balance. It was discovered by Vantia from its extensive drug candidate library.

The double-blind, placebo-controlled, dose-response study was designed to investigate the pharmacodynamics and pharmacokinetics of single and repeated oral doses of VA106483. The trial involved 27 elderly men aged 65 years or more with a history of nocturia.

Based on these results, Vantia now plans to advance VA106483 into a larger Phase IIb clinical efficacy study in the second half of 2009.

Dr Jim Phillips, CEO of Vantia Therapeutics, said 'VA106483 was discovered and has been developed by Vantia based on its small molecule drug development expertise and is the first of several potentially high-value drug candidates in our pipeline. The c
'/>"/>

SOURCE Vantia Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3

Related medicine technology :

1. Vantia Therapeutics Pipeline Continues to Mature
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
4. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
5. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
6. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
7. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
8. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
9. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
10. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
11. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)...   Regulus Therapeutics Inc . ( NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that ... Officer and Executive Vice President, Finance, will present a ... Conference on Wednesday, May 29, 2013 at 3:30 pm ... Boston Waterfront Hotel. The presentation will be ...
(Date:5/21/2013)... , May 21, 2013 On ... impressive new product developments at the Special Libraries Association PHTD ... of unerring focus on product literature databases and workflow solutions ... the occasion," said founding director Nigel Johnson ... of benefit to our clients and what better forum to ...
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
Breaking Medicine Technology:Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2
... N.J., April 8, 2011 Unity Management Group, ... a Health Resource Company specializing in Physician, and ... Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, ... Inc. ("UNITY") (OTCMARKETS: UYMG) announced today it has ...
... 8, 2011 Xeridiem™ Medical Devices (xeridiem) is ... Excellence Award (MDEA).  This international award was for ... Clearance System (PleuraFlow ATC), developed by Clear Catheter ... the design and development for manufacturability, supported the ...
Cached Medicine Technology:Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press 2Unity Management Group, Inc. MCC Receives First Major Order for B&D Italia Tablet Press 3Xeridiem Medical Devices Receives MD+DI 2011 Medical Design Excellence Award (MDEA). 2
(Date:5/21/2013)... of the adenoids and tonsils, is performed 500,000 times ... treatment for children with obstructive sleep apnea. However, ... executive functioning, behavior, sleep apnea symptoms, and quality of ... A study led by Susan Redline, MD, MPH, ... and Associate Clinic Director of the Division of Sleep ...
(Date:5/21/2013)... Harbor, Florida (PRWEB) May 21, 2013 ... agency, announced today that they have redesigned their website ... a nude beach, pool, hot tubs, bars and dining. ... this nudist resort including sales and guest reviews, will ... island of Jamaica itself, including pages on culinary local ...
(Date:5/21/2013)... 2013 The American Diabetes Association ( ... the United States of America are affected with peripheral ... great risk of developing peripheral neuropathy which unfortunately makes ... ADA further goes on saying that the disease usually ... 2 million new cases are diagnosed every year in ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Aggressive treatment ... many older patients with underlying medical conditions, a ... such as surgery, radiation and radioactive seed implants, ... dysfunction, urinary incontinence and bowel problems, explained researchers ... They found that older patients with ...
(Date:5/21/2013)... president for research and economic development will urge ... generation of supercomputers designed to tackle complex societal ... , Daniel Reed will appear at a hearing ... on Energy, titled, "America,s Next Generation Supercomputer: The ... in Room 2318 of the Rayburn House Office ...
Breaking Medicine News(10 mins):Health News:Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms 2Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2Health News:Neuracel Aims to Reduce Peripheral Neuropathy Pain 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Iowa VP for Research addresses next-generation supercomputers at congressional hearing 2
... RECEIVES EXCLUSIVE U.S. RIGHTS AND WILL RECEIVE A ROYALTY ON ... 19 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX: ... restructured its agreement with Novartis Pharma AG ("Novartis") to simplify ... among other things, receive exclusive U.S. rights to the Visudyne(R) ...
... Vancouver ... named as one of the Top Employers in BC for 2010. The annual list ... including employee benefits, community involvement and work atmosphere. , ... Vancouver, B.C. (Vocus) October 19, 2009 -- Vancouver based ...
... , ... expert, Dr. Matthew Loop, launches a new, first-of-a-kind club aimed at helping fellow chiropractors ... ... 2009 -- Matthew Loop, DC is proud to announce the release of a new, ...
... In her new ... the company - from facilities in Rhode Island to those in Hawaii. , ... Cleveland, TN (Vocus) October 18, 2009 -- ... president of interior design. ,    ,Neiman most recently served as one of Life Care,s interior ...
... congenita (DKC) is an autosomal dominant disease that leads to ... skin, nails, bone marrow, lungs and gut. Patients with DKC ... of fatal infections and cancer. Many die before the age ... trying to treat its symptoms. At the heart of DKC ...
... Homecare providers and their clients from across the state will ... tomorrow morning in advance of a court hearing on a ... disabled from losing critical in-home care services. , Advocates for ... UDW Homecare Providers Union (AFSCME Local 3930) and ...
Cached Medicine News:Health News:QLT restructures Visudyne(R) agreement 2Health News:QLT restructures Visudyne(R) agreement 3Health News:QLT restructures Visudyne(R) agreement 4Health News:Clearlycontacts.Ca Named as One of Bc's Top Employers 2Health News:Clearlycontacts.Ca Named as One of Bc's Top Employers 3Health News:Chiropractic Marketing Online Coach Launches First-of-a-Kind Wealth Club for Chiropractors 2Health News:Neiman Named Life Care's Vice President of Interior Design 2Health News:Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy 2Health News:Homecare Recipients and Providers to Rally against Cuts in IHSS Program; Hearing on Lawsuit in Oakland Federal Court Monday 2
... are becoming very popular only a few ... the pack. Explore why MediTalk is rapidly ... and practice administrators. An EMR designed by ... doctors see patients quickly and efficiently while ...
Transfer your exams to AltaPoint with our EMR Exam Word Lists. Document systems as normal and annotate exceptions to the systems in the exam. AltaPoint EMR is configured to allow a specialty to cust...
MediNotes e is an EMR design which utilizes a "tab concept for navigation. MediNotes e can display multiple patients, encounter notes, workflow items, patient flow, messages, alerts, and more, all in...
... Software developed a touchscreen EHR and is ... a user can choose to use a ... maintain eye contact while recording encounter results. ... EHR also runs on a pen tablet ...
Medicine Products: